Global and local literature screening and review

The MAH is required to regularly screen the published medical and scientific literature, to ensure that any mention of their products is duly noted and reported to competent authorities. DADA pharmacovigilance staff is experienced in carrying out this activity on your behalf and can comprehensively manage your literature screening requirements in a cost-effective manner in conjunction with writing periodic safety reports and signal evaluation documents for your products. Our weekly search is not only limited to identification of individual case safety reports, but also includes detection of potential safety issues. Per your requirements, we can also conduct local literature screening in our territories.
In addition, we carry out ad hoc literature searches for purposes of signal evaluation or for identifying safety concerns for inclusion in PSURs.